Peyronie's Disease
Peyronie's Disease: An Outcomes-Based Guide to Non-Surgical and Novel Treatment Modalities.
February 13, 2023
Improvement in the ability to have sex in patients with Peyronie's disease treated with Collagenase Clostridium histolyticum.
January 23, 2023
The Immunological Microenvironment and the Emerging Role of Stem Cells Therapy in Peyronie's Disease: A Systematic Narrative Review.
January 9, 2023
Collagenase Clostridium histolyticum Treatment Improves Degree of Curvature in Peyronie's Disease with Calcified Plaques.
January 2, 2023
Role of Oxidative Stress in Peyronie's Disease: Biochemical Evidence and Experiences of Treatment with Antioxidants.
December 26, 2022
Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's disease.
December 19, 2022
Global Perspective on the Management of Peyronie's Disease.
October 31, 2022
A Consistent Lack of Consistency in Defining the Acute and Chronic Phases of Peyronie's Disease: A Review of the Contemporary Literature.
October 24, 2022
Improved Peyronie's Disease Curvature Outcomes Using a Novel Collagenase Administration Protocol.
October 17, 2022
Patients with Peyronie's disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series.
October 10, 2022
Significant inverse association of testosterone level with penile deformity severity in Japanese males with Peyronie's disease.
October 3, 2022
Full Regression of Peyronie's Disease Plaque Following Combined Antioxidant Treatment: A Three-Case Report.
September 26, 2022
Diagnosis and treatment patterns of Peyronie's disease among different racial, ethnic, and regional groups in the Veterans Affairs healthcare system.
September 26, 2022